Where does BioLoomics's cap table come from?

Share classes are assembled from certificates of incorporation, priced-round filings, and disclosures across BioLoomics's 4 recorded funding rounds.

Premier Alternatives

BioLoomics

Boulder, CO · Founded 2019 · Privately Held (backing)

Developer of antibody-based therapeutics designed for enhanced drug delivery in oncology. BioLoomics is based in Boulder, CO and was founded in 2019. Its last reported valuation was $22.4 million in Mar 2023. It has raised $10.4 million across 4 recorded rounds; the latest was a $450,000 seed round in Aug 2025.

Last reported valuation

$22.4M

Oct 2026

Priced at

—

Total raised

$10.4M

Last round

Seed Round

Aug 2025

Cap table — not yet on record

BioLoomics's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.

Pro members can request priority coverage with a 48-hour turnaround.

Free account

More of BioLoomics with a free account

·The complete investor list: 12 names
·Watch BioLoomics: the Monday email on marks, rounds and moves

Create free account

No card required

Membership and data by Private Market View

Frequently asked about BioLoomics

Where does BioLoomics's cap table come from?: Share classes are assembled from certificates of incorporation, priced-round filings, and disclosures across BioLoomics's 4 recorded funding rounds.